Chemistry professor and UWM alum co-found a start-up to develop a breast cancer treatment
Triple negative breast cancer (TNBC) is a particularly aggressive form of breast cancer. Patients are treated with chemotherapy, which can cause debilitating side effects. A new start-up called SynXT Therapeutics aims to bring some hope to those patients. Founded by …








